People Background Check
Find People:

John Graham Rudge, Age 55136 Valley Rd, Katonah, NY 10536

Get Report
Known as:
John G Rudge John Rudge Graham Kiesha Smith
Related to:
Bronley Rudge 39

John Rudge Phones & Addresses

136 Valley Rd, Katonah, NY 10536

200 86Th St, New York, NY 10024

340 87Th St, New York, NY 10024

Fort Worth, TX

Chappaqua, NY

Westchester, NY

Hanover, NH

Show more

Mentions for John Graham Rudge

John Rudge resumes & CV records

Resumes

John Rudge Photo 37

Partner

Location:
New York, NY
Industry:
Venture Capital & Private Equity
Work:
Lexington Partners since Jul 2001
Principal Morgan Stanley Aug 1999 - Apr 2001
Associate The Chase Manhattan Bank Jul 1995 - Jun 1997
Analyst Sanford C. Bernstein Mar 1993 - May 1995
Associate Portfolio Manager
Education:
Dartmouth College - The Tuck School of Business at Dartmouth 1997 - 1999
MBA Middlebury College 1988 - 1992
BA, American Studies Horace Greeley High School 1984 - 1988
Skills:
Private Equity, Investments, Investment Banking, Alternative Investments, Funding, Valuation, Lbo, Due Diligence, Corporate Finance, Financial Modeling, Portfolio Management, Investment Management
John Rudge Photo 38

Director, Target Gene Delivery At Regeneron Pharmaceuticals Inc

Location:
600 west Main St, Jefferson City, MO 65101
Industry:
Biotechnology
Work:
Regeneron Pharmaceuticals, Inc.
Director, Target Gene Delivery at Regeneron Pharmaceuticals Inc
John Rudge Photo 39

John Rudge

Publications & IP owners

Wikipedia

John Rudge Photo 40

John Rudge

John Robert Rudge (born 21 October 1944) is an English former football player and football manager. He is currently working as the director of football at Stoke City.
John Rudge Photo 41

John Charlt Rudge

John Charlton Rudge (born 12 March 1944) is the titular head of the Grand Duchy of Avram, an Australian micronation. He also served one term in the Tasmanian House

Us Patents

Method Of Tumor Regression With Vegf Inhibitors

US Patent:
7354578, Apr 8, 2008
Filed:
Jun 4, 2004
Appl. No.:
10/860958
Inventors:
Jessica Kandel - New York NY, US
Jocelyn Holash - Alameda CA, US
Darrell Yamashiro - Westwood NJ, US
Jianzhong Huang - New York NY, US
George Yancopoulos - Yorktown Heights NY, US
John Rudge - Mahopac NY, US
Assignee:
Regeneron Pharmaceuticals, Inc. - Tarrytown NY
International Classification:
A61K 38/18
C07K 14/71
C12N 15/62
US Classification:
4241341, 4241921, 514 2, 514 12, 530350, 536 234
Abstract:
Methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating vascular endothelial growth factor (VEGF)-mediated activity to a subject in need thereof such that the tumor is regressed or inhibited. The method of the invention results in a reduction of tumor size and inhibition of tumor metastases. This method is particularly useful for patients suffering from bulky, metastatic cancers.

Methods Of Treating Inflammatory Skin Diseases

US Patent:
2003001, Jan 23, 2003
Filed:
Jan 31, 2001
Appl. No.:
09/773877
Inventors:
Yuping Xia - Cortlandt Manor NY, US
John Rudge - Mahopac NY, US
George Yancopoulos - Yorktown Heights NY, US
International Classification:
A61K038/18
US Classification:
514/012000
Abstract:
Modified chimeric polypeptides with improved pharmacokinetics are disclosed. Specifically, modified chimeric Fit1 receptor polypeptides that have been modified in such a way as to improve their pharmacokinetic profile are disclosed. Also disclosed are methods of making and using the modified polypeptides including but not limited to using the modified polypeptides to decrease or inhibit plasma leakage and/or vascular permeability in a mammal. Also disclosed are methods of treating diseases in which plasma leakage and/or vascular permeability occurs, for example, inflammatory skin diseases.

Methods Of Treating Inflammatory Skin Diseases

US Patent:
2004026, Dec 30, 2004
Filed:
Apr 16, 2004
Appl. No.:
10/825739
Inventors:
Yuping Xia - Cortlandt Manor NY, US
John Rudge - Mahopac NY, US
George Yancopoulos - Yorktown Heights NY, US
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
Methods of treating diseases in which plasma leakage and/or vascular permeability occurs, for example, inflammatory skin diseases, particularly psoriasis, with a vascular endothelial growth factor (VEGF) antagonist. Further included are methods for enhacing wound healing with a VEGF antagonist.

Possible Relatives

David J Rudge  Denise A Rudge  Edward M Rudge  Karen A Rudge  Linda J Rudge  Michael J Rudge  Richard C Rudge  John M Johnson  John Stamps  John R Stan 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.